2023 # ECPR55 Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain 

Measure Title: Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain

Measure Description: Percentage of Adult Patients Who Were Prescribed an Opiate Who Were Not Prescribed a Long-Acting (LA) or Extended-Release (ER) Formulation and for Whom the Prescription Duration Was Not Greater than 3 days for Acute Pain

Denominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS Opiate prescribed PLUS ICD-10 diagnosis codes for pain, strains, sprains, lacerations, open wounds and fractures PLUS Disposition of Discharged

Numerator: Patients who were not prescribed a long-acting (LA) or extended-release (ER) opiate, and not prescribed an opiate and any opiate prescription for greater than 3 days duration

Denominator Exclusions: None

Denominator Exceptions: LA/ER formulation opiate prescribed for terminal (late-stage) cancer, comfort care measures, palliative care, or coordinated plan of care for Medication Assisted Treatment (MAT)

NQF ID Number: N/A

NQS Domain: Effective Clinical Care

High Priority Measure: Yes

Measure Type: Process

Includes Teleheatlh: Yes

Inverse Measure: No

Proportional Measure: Yes

Continuous Variable Measure: No

Ratio Measure: No

Number of performance rates to be calculated and submitted: 1

Risk-Adjusted Status: No

Care Setting: Ambulatory; Ambulatory Care: Clinician Office/Clinic; Ambulatory Care: Hospital; Ambulatory Care: Urgent Care; Emergency Department and Services; Hospital; Hospital Outpatient; Outpatient Services

Submission Pathway: Traditional MIPS


Tags

QCDR-EACCR-2023